Tetracyclines have long been considered useful adjuncts in peridontal therapy based on their antimicrobial efficacy against putative periodontopathogens. However, recently these drugs were found to inhibit mammalian collagenases and several other matrix metalloproteinases (MMPs) by a mechanism independent of their antimicrobial activity. Evidence is presented that this property may be therapeutically useful in retarding pathologic connective tissue breakdown, including bone resorption. The experiments leading to this discovery are described and possible mechanisms are addressed, including the specificity of tetracyclines' anti-collagenase activity, the role of the drugs' metal ion (Zn2+, Ca2+)- binding capacity, and the site on the tetracycline molecule responsible for this nonantimicrobial property. Of extreme interest, the tetracycline molecule has been chemically modified in multiple ways, generating a new family of compounds called CMTs (chemically modified tetracyclines) that lack antimicrobial but still retain anti-collagenase activity. The first of these CMTs, 4-de-dimethylaminotetracycline, was found not to produce a major side-effect of antimicrobial tetracycline therapy- its administration to experimental animals did not result in the emergence of tetracycline-resistant microorganisms in the oral flora and gut. Numerous examples of the clinical potential of this non-antimicrobial property of tetracyclines in the treatment of periodontal and several medical diseases (e.g., sterile corneal ulcers, rheumatoid arthritis, skin bullous lessions, tumor-induced angiogenesis and metastasis) are discussed.
References
1.
Slots, J. and Rosling, B.G., Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline, J. Clin. Periodontol., 10, 465, 1983.
2.
Slots, J., Mashimo, P., Levine, M.J., and Genco, R.J., Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing as an adjunct to tetracycline, J. Periodontol., 50, 495, 1979.
3.
Lindhe, J., Liljenberg, B., and Adielsson, B., Effect of long-term tetracycline therapy on human periodontal disease, J. Clin. Periodontol., 10, 590, 1983.
4.
Ciancio, S.G., Mather, M.L., and McMullen, J.A., An evaluation of minocycline in patients with periodontal disease, J. Periodontol., 51, 530, 1980.
5.
Gordon, J.M., Walker, C.B., Murphy, J.C., Goodson, J.M., and Socransky, S.S., Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. I. Concentrations in crevicular fluid after repeated doses, J. Periodontol., 52, 609, 1981.
6.
Park, J.K. and Dow, R.C., The uptake and localization of tetracycline in human blood cells, Br. J. Exp. Pathol., 51, 179, 1970.
7.
Baker, P., Evans, R., Coburn, R., and Genco, R., Tetracycline and its derivatives strongly bind to and are released from the tooth surface in an active form, J. Periodontol., 54, 580, 1983.
8.
Terranova, V.P., Franzetti, L.C., Hick, S., DiFlorio, R.M., Lyall, R.M., Wikesjo, U.M.E., Baker, P.J., Christersson, L.A., and Genco, R.J., A biochemical approach to periodontal regeneration: tetracycline treatment of dentin promotes fibroblast adhesion and growth, J. Periodont. Res., 21, 330, 1986.
9.
Somerman, M.J., Foster, R.A., Vorsteg, G., Progebin, K., and Wynn, R.L., Effects of minocycline on fibroblast attachment and spreading, J. Periodont. Res., 23, 154, 1988.
10.
Al-Ali, W., Bissada, N.F., and Greenwell, H., The effect of local doxycycline with and without tricalcium phosphate on the regenerative healing potential of periodontal osseous defects in dogs, J. Periodontol., 60, 582, 1989.
11.
Lynch, W.S. and Bergfeld, W.F., Pyoderma gangrenosum responsive to minocycline hydrochloride, Cutis, 21, 535, 1978.
12.
Plewig, G. and Schopf, E., Anti-inflammatory effects of antimicrobial agents: an in vivo study, J. Invest. Dermatol., 65, 532, 1975.
Humbert, P., Renaud, A., Laurent, L., and Agache, P., Tetracyclines for dystrophic epidermolysis bullosa, Lancet, 1, 277, 1989.
15.
Golub, L.M., Lee, H.M., Lehrer, G., Nemiroff, A., McNamara, T.F., Kaplan, R., and Ramamurthy, N.S., Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action, J. Periodont. Res., 18, 516, 1983.
16.
Golub, L.M., Ramamurthy, N., McNamara, T.F., Gomes, J.B., Wolff, M., Casino, A., Kapoor, A., Zambon, J., Ciancio, S., Schneir, M., and Perry, H., Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease, J. Periodont. Res., 19, 651, 1984.
17.
Gomes, B.C., Golub, L.M., and Ramamurthy, H.S., Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture, Experientia, 40, 1273, 1984.
18.
Ramamurthy, N.S., Zebrowski, E.J., and Golub, L.M., The effect of alloxan diabetes on gingival collagen metabolism in the rat, Arch. Oral Biol., 17, 1551, 1972.
19.
Ramamurthy, N.S., Zebrowski, E.J., and Golub, L.M., Insulin reversal of alloxan diabetes induced changes in gingival collagen metabolism of the rat, J. Periodont. Res., 9, 199, 1974.
20.
Golub, L.M., Garant, P.R., and Ramamurthy, N.S., Inflammatory changes in gingival collagen in the alloxan diabetic rat, J. Periodont. Res., 12, 402, 1977.
21.
Golub, L.M., Greenwald, R.A., Zebrowski, E.J., and Ramamurthy, N.S., The effect of experimental diabetes on the molecular characteristics of rat tail tendon collagen, Biochim. Biophys. Acta, 534, 73, 1978.
22.
Golub, L.M., Nicoll, G.A., Iacono, V.J., and Ramamurthy, N.S., In vivo crevicular leukocyte response to a chemotactic challenge: inhibition by experimental diabetes, Infect. Immun., 37, 1013, 1982.
23.
Cianciola, L.J., Genco, R.J., Patters, M.R., McKenna, J., and Van Oss, C.J., Defective polymorphonuclear leukocyte function in a human periodontal disease, Nature, 265, 445, 1977.
24.
Clark, R.A., Page, R.C., and Wilde, C., Defective neutrophil chemotaxis in juvenile periodontitis, Infect. Immun., 12, 694, 1977.
25.
Ramamurthy, N.S., Zebrowski, E.J., and Golub, L.M., Collagenolytic activity of alloxan diabetic rat gingivae, Diabetes, 22, 272, 1973.
26.
Gross, J. and Lapiere, C.M., Collagenolytic activity in amphibian tissues: a tissue culture assay, Proc. Natl. Acad. Sci. U.S.A., 48, 1014, 1962.
27.
Harris, E.D., Welgus, H.G., and Krane, S.M., Regulation of the mammalian collagenases, Coll. Rel. Res., 4,493, 1984.
28.
Ramamurthy, N.S. and Golub, L.M., Diabetes increases collagenase activity in extracts of rat gingiva and skin, J. Periodont. Res., 17, 455, 1983.
29.
McNamara, T.F., Ramamurthy, N.S., Mulvihill, J.E., and Golub, L.M., The development of an altered gingival crevicular microflora in the alloxan-diabetic rat, Arch. Oral Biol., 27, 217, 1982.
30.
Chang, K.M., Ramamurthy, N.S., McNamara, T.F., Genco, R.J., and Golub, L.M., Infection with a Gram-negative organism stimulates gingival collagenase production in non-diabetic and diabetic germfree rats, J. Periodont. Res., 23, 239, 1988.
31.
Golub, L.M., McNamara, T.F., D'Angelo, G., Greenwald, R.A., and Ramamurthy, N.S., A non-antibacterial chemically modified tetracycline inhibits mammalian collagenase activity, J. Dent. Res., 66, 1310, 1987.
Schneir, M., Ramamurthy, N.S., and Golub, L.M., Minocycline treatment of diabetic rats increases skin collagen production and mass; possible causative mechanisms, Matrix, 10, 112, 1990.
34.
Ramsammy, L., Ramamurthy, N., Greenwald, R., Arbeit, L., and Golub, L.M., Tetracycline administration ameliorates diabetic rat kidney dysfunction, Kidney Int., submitted.
35.
Burns, F.R., Stack, M.S., Gray, R.D., and Paterson, C.A., Inhibition of purified collagenase from alkaline-burned rabbit corneas, Invest. Opthalmol. Vis. Sci., 30, 1569, 1989.
36.
Golub, L.M., Wolff, M., Lee, H.M., McNamara, T.F., Ramamurthy, N.S., Zambon, J., and Ciancio, S.G., Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources, J. Periodont. Res., 20, 12, 1985.
37.
Golub, L.M., Ciancio, S., Ramamurthy, N.S., Leung, M., and McNamara, T.F., Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans, J. Periodont. Res., 25, 321, 1990.
38.
Greenwald, R.A., Golub, L.M., Laveites, B., Ramamurthy, N.S., Laskin, R., and Gruber, B., Tetracyclines inhibit human synovial collagenase in vivo and in vitro, J. Rheumatol., 14, 28, 1987.
39.
Greenwald, R.A., Simonson, B.G., Moak, S.A., Rush, S.W., Ramamurthy, N.S., Laskin, R.J., and Golub, L.M., Inhibition of epiphyseal cartilage collagenase by tetracyclines in low phosphate rickets in rats, J. Orthopaed. Res., 6, 695, 1988.
40.
Ramamurthy, N.S., Vernillo, A., Lee, H.M., Golub, L.M., and Rifkin, B.R., The effect of tetracyclines on collagenase activity in UMR 106-01 rat osteoblastic osteosarcoma cells, Res. Commun. Chem. Pathol. Pharmacol., 70, 323, 1990.
41.
Perry, H.D., Hodes, L.W., Seedor, J.A., Donnenfeld, E.D., McNamara, T.F., and Golub, L.M., Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model, Ann. Ohpthalmol., submitted.
42.
Zucker, S., Lysik, R.M., Ramamurthy, N.S., Golub, L.M., Wieman, J.M., and Wilkie, D.P., Diversity of plasma membrane proteinases in mouse melanoma cells: inhibition of collagenolytic and cytolytic activity by minocycline, J. Natl. Cancer Inst., 75, 517, 1985.
43.
Zucker, S., Wieman, J., Lysik, R.M., Imhof, B., Nagase, H., Ramamurthy, N.S., Liotta, L.A., and Golub, L.M., Gelatin-degrading type IV collagenase isolated from human small cell lung cancer, Invas. Metast., 9, 167, 1989.
44.
Maehara, R., Hinode, D., Terai, H., Sat, M., Nakamura, R., Matsuda, M., Tanaka, T., and Sugihara, K., Inhibition of bacterial and mammalian collagenolytic activities by tetracyclines, J. Jpn. Assoc. Periodontol., 30, 182, 1988.
45.
Yanagimura, M., Koike, F., and Hara, K., Collagenase activity in gingival crevicular fluid and inhibition by tetracyclines, J. Dent. Res., 68 (Spec. Iss.), 1691, 1989.
46.
Ramamurthy, N.S., Lee, H.M., Vidal, A.M., McNamara, T.F., Rifkin, B., and Golub, L.M., The substantivity of the anti-collagenase activity of minocycline in vivo, J. Dent. Res., 65 (Spec. Iss.), IADR Abstr. no. 1015, 1986.
47.
Greenwald, R.A., Tetracycline derivatives as potential inhibitors of connective tissue degradation, Drug News Perspect., 3, 161, 1990.
48.
Golub, L.M., Greenwald, R., Ramamurthy, N., Zucker, S., Ramsammy, L., and McNamara, T., Tetracyclines inhibit metalloproteinases: in vivo effects in arthritic and diabetic rats and new in vitro studies, in Matrix Metalloproteinase Conference, Proceedings, Destin, FL, Abstr. no. 63, p. 43, Sept. 11-15, 1989.
49.
Lee, H.M., Golub, L., Suzuki, K., Nagase, H., Sorsa, T., Uitto, V.J., and Ramamurthy, N., Specificity of the anti-collagenase activity of tetracyclines, J. Dent. Res., 70 (Spec. Iss.), IADR Abstr. no. 1621, 1991.
50.
Sorsa,T., personal communication; oral presentation at the 8th Int. Conf. on Periodontal Res, San Antonio, Texas, Nov. 17, 1990.
51.
Sorsa, T., Uitto, V.J., Suomalainen, K., Vaukinen, M., and Lindy, S., Comparison of interstitial collagenases from human gingival, sulcular fluid and polymorphonuclear leukocytes, J. Periodont. Res., 23, 386, 1988.
52.
Robertson, P.B., Lanz, M., Manidra, P.T., Kornman, K.S., Truromel, C.L., and Holt, S.C., Collagenolytic activity associated with Bacteriodes species and Actinobacillus actinomycetemcomitans, J. Periodont. Res., 17, 275, 1982.
53.
Tschesche, H., Fedrowitz, J., Konhwert, U., Macartney, H.W., and Michaelis, J., Interestitial collagenase, gelatinase and a specific type IV/V (basement membrane) collagen degrading proteinase from human leukocytes, in Proteinases in Inflammation and Tumor Invasion, Tschesche, H., Ed., Walter de Gruyter, New York, 1986, 225.
54.
Chang, K.M., Ramamurthy, N.S., and Golub, L.M., Minocycline inhibits matrix-degrading enzymes in rat gingiva, J. Dent. Res., 68 (Spec. Iss.), AADR Abstr. no. 130, 1989.
55.
Lee, H.M., Golub, L.M., Gwinnett, A.J., and Ramamurthy, N.S., Minocycline inhibits collagenase and elastase produced by rat macrophages in cell culture, J. Dent. Res., 64 (Spec. Iss.), IADR Abstr. no. 1175, 1985.
56.
Arsenis, C., Greenwald, R.A., Moak, S.A., and Laskin, R.S., Inhibition of neutral metalloproteinase activities in epiphyseal and articular cartilages by tetracyclines both in vivo and in vitro, Trans. Orthopaed. Res. Soc., 15, 268, 1990.
57.
Ito, A. and Nagase, H., Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase, Arch. Bioch. Biophys., 267, 211, 1988.
58.
Mitscher, L.A., The Chemistry of the Tetracycline Antibiotics, Marcel Dekker, New York, 1978, 172.
59.
McCormick, J.R.D., Fox, S.M., Smith, L.L., Bitler, B.A., Reichenthal, J., Origoni, V.E., Muller, W.H., Winterbottom, R., and Doerschuk, A.P., Studies of the reversible epimerization occurring in the tetracycline family. The preparation, properties and proof of structure of some 4-epi-tetracyclines, J. Am. Chem. Soc., 79, 2849, 1957.
60.
Boothe, J.H., Bonvicino, G.E., Waller, C.W., Petisi, J.P., Wilkinson, R.W., and Broschard, R.B., Chemistry of the tetracycline antibiotics. I. Quaternary derivatives, J. Am. Chem. Soc., 80, 1654, 1958.
61.
McNamara, T.F., Golub, L.M., D'Angelo, G., and Ramamurthy, N.S., The synthesis and characterization of a non-antibacterial chemically-modified tetracycline (CMT), J. Dent. Res., 65 (Spec. Iss.), IADR Abstr. no. 515, 1986.
62.
McNamara, T.F., Golub, L.M., Yu, Z., and Ramamurthy, N., Chemically modified tetracyclines (CMTs) fail to induce microbial resistance, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1091, 1990.
63.
Rifkin, B., Sanavi, F., Gomes, B., Kleckner, A., McNamara, T., Ramamurthy, N., and Golub, L., The effects of minocycline and non-antibiotic tetracycline on parathyroid hormone stimulated bone resorption in vitro, J. Bone Min. Res., 1991, submitted.
64.
Seltzer, J.L., Eschback, M.L., Winberg, J. 0., Bauer, E.A., Eisen, A.Z., and Weingarten, H., Eriochrome black T inhibition of human skin collagenase, but not gelatinase, using both protein and synthetic substrates, Collagen Rel. Res., 7, 399, 1987.
65.
Valcavi, U., Companella, G., and Pacini, N., Pirazol-derivati della tetracyclina e clorotetraciclina, Gazz. Chem. Ital., 93, 916, 1963.
66.
Yu, Z., Golub, L., and Ramamurthy, N., unpublished data, 1990.
67.
Skinner, H.C.W. and Nalbandian, J., Tetracycline and mineralized tissue, Yale J. Biol. Med., 48, 377, 1975.
68.
Day, S.T., Crouthamel, W.D., Martinelli, L.C., and Ma, J.K.H., Mechanism of fluorometric analysis of tetracycline involving metal complexation, J. Pharmac. Sci., 67, 1518, 1978.
Karakiulakis, G., Missirlis, E., and Margoudakis, M.E., Mode of action of Razoxane: inhibition of basement membrane collagen-degradation by a malignant tumor enzyme, Methods Find. Exp. Clin. Pharmacol., 11, 255, 1989.
71.
Sipos, T., Oleniacs, W., and Kellerman, F.A., The effect of collagenase inhibitors on alveolar bone loss due to periodontal disease in desalivated rats, in Matrix Metalloproteinase Conf. Proceedings, Destin, FL, Abstr. no. 64, p. 43, Sept. 11-15, 1989.
72.
Takai, N., Shinohara, M., Yoshida, Y., Ohura, K., Mori, M., and Kakudo, Y., Effect of streptozotocin diabetes on gingivitis in plaque-susceptible rats, J. Dent. Res., 65, 49, 1986.
73.
Ramamurthy, N.S., Lee, H., Vidal, A., McNamara, T., and Golub, L., Effect of non-antimicrobial tetracycline on gingivitis and collagenase activity in ODU-rats, J. Dent. Res., 68 (Spec. Iss.), AADR Abstr. no. 1840, 1989.
74.
McNamara, T.F., Golub, L.M., Yu, Z., and Ramamurthy, N.S., Reduced doxycycline blood levels in humans fail to promote resistant organisms, in Int. Conference on Periodont. Disease: Pathogens and Host Immune Responses, Osaka, Japan, Abstr. no. B54, 100, Sept. 25-27, 1990.
75.
Yu, Z., Leung, M., Ramamurthy, N., McNamara, T., and Golub, L., Serum levels of chemically-modified tetracycline: a comparison to tetracycline, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1092, 1990.
76.
Klausen, B., Evans, R.T., Ramamurthy, N.S., Golub, L.M., Sfintescu, C., Lee, Y.J., Bedi, G., Zambon, J.J., and Genco, R.J., Reduced periodontal bone loss in gnotobiotic rats immunized with Bacteroides gingivalis, J. Oral Microbiol. Immunol., in press.
77.
Chang, K.M., Ramamurthy, N.S., Yu, Z., NcNamara, T.F., and Golub, L.M., Effect of tetracyclines on B. gingivalis - induced alveolar bone loss in rats, J. Dent. Res., 70 (Spec. Iss.), IADR Abstr. no. 1620, 1991.
78.
Yu, Z., Schneir, M., Ramamurthy, N., Leung, M., and McNamara, T., Chemically modified tetracycline prevents collagen loss in diabetic rats: intracellular and extra-cellular mechanisms, J. Dent. Res., 70 (Spec. Iss.), Abstr. no. 1619, 1991.
79.
Golub, L.M., Goodson, J.M., Lee, H.M., Vidal, A.M., McNamara, T.F., and Ramamurthy, N.S., Locally and low-dose systemically administered tetracyclines inhibit tissue collagenase activity: potential new approaches in the treatment of periodontal disease, J. Periodontol., 56, (Spec. Iss.), 93, 1985.
80.
Golub, L.M., Siegal, K., Ramamurthy, N.S., and Mandel, I., Some characteristics of collagenase in gingival crevicular fluid and its relationship to gingival disease in humans, J. Dent. Res., 55, 1049, 1976.
81.
Uitto, V.J. and Raeste, A.M., Activation of latent collagenase of human leukocytes and gingival fluid by bacterial plaque, J. Dent. Res., 57, 844, 1978.
82.
Kryshtalskyj, E., Sodek, J., and Ferrier, J.M., Correlation of collagenolytic enzymes and inhibitors in gingival crevicular fluid with clinical and microscopic changes in experimental periodontitis in the dog, Arch. Oral Biol., 31, 21, 1986.
83.
Villella, B., Cogen, R.B., Bartolucci, A.A., and Birkedal-Hansen, H., Crevicular fluid collagenase activity in health, gingivitis, chronic adult periodontitis and localized juvenile periodontitis patients, J. Periodont. Res., 22, 209, 1987.
84.
McCulloch, C.A.G., Birek, P., Overall, C., Aitken, S., Lee, W., and Kulkarin, G., Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high risk patients: antimicrobial activity and collagenase inhibition, J. Clin. Periodontol., 17, 616, 1990.
85.
Lamster, I., Celenti, R., and Silver, F., A new assay for collagenolytic activity in crevicular fluid, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1738, 1990.
86.
Lamster, I.B., Application of new methodology to the study of gingival crevicular fluid, in New Biotechnology in Oral Research, Myers, H. M., Ed., Karger, New York, 1989, chap. 6.
87.
Schroeder, K., Lee, H., Wolff, M., Ramamurthy, N., and Golub, L.M., Low-dose tetracyclines decrease elastase and β-glucuronidase activities in gingival crevicular fluid, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1090, 1990.
88.
El-Attar, T.M.A., Lin, H.S., and Schultz, R., Effect of minocycline on prostaglandin formation in gingival flbroblasts, J. Periodont. Res., 23, 285, 1988.
89.
Van Baar, H.M.J., Van de Kerkhof, P.C.M., Mier, P.D., and Hopple, R., Tetracyclines are potent scavengers of superoxide radical, Br. J. Dermatol., 117, 131, 1987.
90.
Gabler, W.L. and Creamer, H.C., Effects of tetracycline derivatives on neutrophil functions, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1089, 1990.
91.
Chang, C. and Houck, J.C., Demonstration of the chemotactic properties of collagen, Proc. Soc. Exp. Biol., 134, 22, 1974.
92.
Knauper, V., Reinke, H., and Tschesche, H., Inactivation of human plasma α1-proteinase inhibitor by human PMN leukocyte collagenase, FEBS Lett., 263, 355, 1990.
93.
Desrochers, P.E. and Weiss, S.J., Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase, J. Clin. Invest., 81, 1646, 1988.
94.
Golub, L.M., Wolff, M., Vidal, A.M., Ramamurthy, N.S., and McNamara, T.F., Low-dose minocycline therapy: effects on crevicular fluid collagenase and subgingival microflora, J. Dent. Res., 66 (Spec. Iss.), IADR Abstr. no. 384, 1987.
95.
Golub, L., Greenwald, R., Ramsammy, L., Zucker, S., and Ramamurthy, N., Tetracyclines inhibit metalloproteinases: in vivo effects in arthritic and diabetic rats and new in vitro studies, in Matrix Metalloproteinase Conference, Proceedings, Destin, FL, Sept. 11-15, 1989, Abstr., p. 43.
96.
Eady, E.A., Cove, J.H., Holland, K.T., and Cunliffe, W.J., Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients, Br. J. Dermatol., 122, 233, 1990.
97.
Salomon, S.M., Tetracyclines in ohpthalmology, Surv. Ohpthalmol., 29, 265, 1985.
98.
Baker, P.J., Evans, R.T., Slots, J., and Genco, R.J., Antibiotic susceptibility of anaerobic bacteria from the human oral cavity, J. Dent. Res., 64, 1233, 1985.
99.
Kormnan, K.S. and Karl, E.H., The effect of long-term low-dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis, J. Periodontol., 53, 604, 1982.
100.
Cowen, K.S., Sakamoto, M., and Sakamoto, S., Monensin inhibits collagenase production in osteoblastic cell cultures and also inhibits both collagenase release and bone resorption in mouse calvaria cultures, Biochem. Int., 11, 273, 1985.
101.
Delaisse, J.M., Eeckhout, Y., Sear, C., Galloway, A., McCullagh, K., and Vaes, G., A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture, Biochem. Biophys. Res. Commun., 133, 483, 1985.
102.
Sakamoto, M. and Sakamoto, S., Immunocytochemical localization of collagenase in isolated mouse bone cells, Biomed. Res., 5, 29, 1984.
103.
Sakamoto, S. and Sakamoto, M., Biochemical and immunohistochemical studies on collagenase in resorbing bone in tissue cultures, J. Periodont. Res., 17, 523, 1982.
104.
Otsuka, K., Sodek, J., and Limeback, H., Synthesis of collagenase and collagenase inhibitors by osteoblast-like cells in culture, Eur. J. Biochem., 145, 123, 1984.
105.
Chambers, T.J., Darby, J.A., and Fuller, K., Mammalian collagenase predisposes bone surfaces to osteoclastic resorption, Cell Tissue Res., 241, 671, 1985.
106.
Baron, R., Eeckhout, Y., Neff, L., Francois-Gillet, C., Henriet, P., Delaisse, J.M., and Vaes, G., Affinity purified antibodies reveal the presence of procollagenase in the subosteoclastic bone resorbing compartment, J. Bone Miner. Res., 5 (Suppl. 2), S203, 1990.
107.
Vernillo, A.T., Ramamurthy, N.S., Lee, H.M., and Rifkin, B.R., The effect of phenytoin on collagenase and gelatinase activities in UMR 106-01 rat osteoblastic osteosarcoma cells, Matrix, 10, 27, 1990.
108.
Donahue, H., Iijima, K., Gdigorsky, M., Rubin, C., and Rifkin, G., Tetracycline alters the regulation of cytoplasmic calcium ion in rat osteoclasts, J. Bone Miner. Res., (Abstr.), 1990, in press.
109.
Hough, S., Aviolo, L.V., Bergfeld, M.E., Fallon, M.D., Slatopolsky, E., and Teitelbaum, S.L., Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy, Endocrinology, 108, 2228, 1981.
110.
Shires, R., Teitelbaum, S.L., Bergfeld, M.A., Fallon, M.D., Slatopolsky, E., and Avioli, L.V., The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat, J. Lab. Clin. Med., 97, 231, 1981.
111.
Goodman, W.G. and Hori, M.T., Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization, Diabetes, 33, 825, 1984.
112.
Kaneko, H., Sasaki, T., Ramamurthy, N.S., and Golub, L.M., Tetracycline administration normalizes the structure and acid phosphatase activity of osteoclasts in streptozotocin-induced diabetic rats, Anat. Rec., 227, 427, 1990.
113.
Sasaki, T., Kaneko, H., Ramamurthy, N.S., and Golub, L.M., Tetracycline administration normalizes osteoblast structure and function during experimental diabetes, Anat. Rec., 1991, in press.
114.
Bain, S., Ramamurthy, N., Impeduglia, T., Scolman, S., Golub, L., and Rubin, C., Tetracycline treatment normalizes bone formation in the diabetic rat: a histomorphometric study, J. Bone Miner. Res., 1990, submitted.
115.
Sasaki, T., Ramamurthy, N.S., and Golub, L.M., Insulin-deficient diabetes impairs osteoblast and periodontal ligament fibroblast metabolism but does not affect ameloblasts and odontoblasts: response to tetracycline(s) adminstration, J. Biol. Buccale, 18, 215, 1990.
116.
Schneir, M., Imberman, M., Ramamurthy, N., and Golub, L., The in vivo fractional rate of gingival collagen production in non-diabetic and diabetic rats. Application of a novel approach for quantification- pool expansion, J. Periodont. Res., 21, 56, 1986.
117.
Kao, W.W.-Y., Mai, S.H., Chu, K.L., and Ebert, J., Mechanism for the regulation of post-translational modification of procollagens synthesized by matrix-free cells from chick embryos, J. Biol. Chem., 258, 7779, 1983.
118.
Brinckerhoff, C.E., McMillan, D.M., Dayer, J.M., and Harris, E.D., Jr., Inhibition by retinoic acid of collagenase production in rheumatoid synovial cells, N. Engl. J. Med., 303, 432, 1980.
119.
Brinckerhoff, C.E., Vater, C.A., and Harris, E.D., Jr., Effects of retinoids on rabbit synovial fibroblasts and chondrocytes, in Cellular Interactions, Dingle, J. T. and Gordon, J., Eds., Elsevier/ North Holland, Limerick, Ireland, 1981, 215.
120.
Bauer, E.A., Cooper, T.W., Tucker, D.R., and Esterly, N.B., Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase, N. Engl. J. Med., 303, 776, 1980.
121.
Perry, H.D. and Golub, L.M., Systemic-tetracycline in the treatment of non-infected corneal ulcers, Ann. Ohpthalmol., 17, 742, 1985.
122.
Berman, M.B., Collagenases and corneal ulceration, in Collagen in Normal and Pathological Connective Tissues, Wooley, D. E. and Evanson, J. M., Eds., John Wiley & Sons, New York, 1980, 141.
123.
Perry, H.D., Kenyon, K.R., Lamberts, D.W., Foulkes, G.N., Seedor, J.A., and Golub, L.M., Systemic tetracycline HC1 as adjunctive therapy in the treatment of persistent epithelial defects, Ophthalmology, 93, 1320, 1986.
124.
Seedor, J.A., Perry, H.D., McNamara, T.F., Golub, L.M., Buxton, D.F., and Guthrie, D.S., Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbits, Arch. Ohpthalmol., 105, 268, 1987.
125.
Szmyd, L., Spector, S.M., Perry, H.D., Seedor, J.A., McNamara, T.F., and Golub, L.M., Topical tetracycline in the treatment of alkali induced corneal ulceration in the rabbit, Invest. Ohpthalmol., 27 (Suppl.), 208, 1986.
126.
Levy, J.H. and Katz, H.R., Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit, Ann. Ohpthalmol., 22, 179, 1990.
127.
Breeudveld, F.C. and Trentham, D.E., Suppression of collagen and adjuvant arthritis by a tetracycline, Arthritis Rheum., 31 (Asbstr. Suppl.), R9, 1988.
128.
Sewell, K.L., Fury, E., Dynesius, R., and Trentham, D.E., Evidence that minocycline suppresses collagen and adjuvant arthritis by altering the expression of T cell derived collagen-binding proteins, Arthritis Rheum., 32 (Suppl. 4), S134, 1989.
129.
Greenwald, R.A. and Moak, S.A., unpublished data, 1989.
130.
Greenwald, R.A., Golub, L.M., Ramamurthy, N.S., and McNamara, T.F., Direct detection of collagenase and gelatinase in periarticular tissue from adjuvant arthritic rats: inhibition by tetracyclines and potential amelioration of bone destruction, Trans. Orthopaed. Res. Soc., 15, 270, 1990.
131.
Jeffcoat, M.K., Williams, R.C., Reddy, M.S., English, R., and Goldhaber, P., Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism, J. Periodont. Res., 23, 381, 1988.
132.
Skinner, M., Cathcart, E.S., Mills, J.A., and Pinals, R.S., Tetracycline in the treatment of rheumatoid arthritis: a double blind controlled study, Arthritis Rheum., 14, 727, 1971.
133.
Breedveld, F.C., Dijkmans, B.A.C., and Mattie, H., Minocycline treatment for rheumatoid arthritis: an open dose finding study, J. Rheumatol., 17, 43, 1990.
134.
Leber, R., Knecht, R., and Hasslacher, C., Degradation of glomerular basement membrane in diabetes. n. Proteolytic activity of diabetic and non-diabetic glomeruli, Res. Exp. Med., 187, 347, 1987.
135.
Ramsammy, L., Ramamurthy, N., Lee, H., Greenwald, R., and Golub, L., Tetracycline inhibits diabetic rat kidney type IV collagenolytic activity and proteinuria, Clin. Res., 37, 459A, 1989.
136.
Lin, A.N. and Carter, D.M., Epidermolysis bullosa: when the skin falls apart, J. Pediatr., 114, 349, 1989.
137.
Bauer, E.A., Ludman, H., Goldberg, J., Berkowitz, R.L., and Holbrook, K.A., Antenatal diagnosis of recessive dystrophic epidermolysis bullosa: collagenase expression in cultured fibroblasts as a biochemical marker, J. Invest. Dermatol., 87, 597, 1986.
138.
Cooper, T.W. and Bauer, E.A., Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis bullosa: a comparison of short- and long-term treatment, Arch. Dermatol., 120, 490, 1984.
139.
Lin, A.N., Stem, R.S., Caldwell-Brown, D., and Carter, D.M., Phenytoin for recessive dystrophic epidermolysis bullosa, J. Invest. Dermatol., 92 (Abstr.) 1989, 472.
140.
Schneider, B., Greenwald, R., Ramamurthy, N., and Golub, L., Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines, unpublished data, 1990.
141.
Golub, L.M., Rifkin, B.R., Ramamurthy, N.S., Vernillo, A., Sanavi, F., and McNamara, T.F., Chemically-modified tetracyclines as probes of collagenase in bone resorption, in 8th Int. Conf. on Periodontal Res, San Antonio, Texas, Nov. 15-18, 1990, Abstract.
142.
Powers, J., Gupton, B., Lively, M., Nishino, N., and Whitley, R., Synthetic inhibitors of granulocyte elastase and cathepsin G, in Neutral Proteases of Human Polymorphonuclear Leukocytes, Havemann, K. and Janoff, A., Eds., Urban and Schwarzenberg, Baltimore, 1978, 221.
143.
Fishman, W.H. and Bernfeld, P., Glucuronidases, in Methods in Enzymology, Vol. I, Colowick, S. P. and Kaplan, N. 0., Eds., Academic Press, New York, 1955, 262.
144.
Stahl, P.D. and Touster, O., β-Glucuronidase from rat liver lysozomes, in Methods in Enzymology, Vol. 28, Complex Carbohydrates Part B, Ginsberg, V., Ed., Academic Press, New York, 1972, 814.
145.
Karakiulakis, G., Missirlis, E., and Maragoudakis, M.E., Mode of action of Razoxane: inhibition of basement membrane collagen-degradation by a malignant tumor enzyme, Methods Find. Exp. Clin. Pharmacol., 11, 255, 1989.
146.
Tamargo, R.J., Bok, R.A., and Brem, H., Angiogenesis inhibition by minocycline, Cancer, Res., 51, 672, 1991.
